AQP5 small interfering RNA (siRNA) treated LAMA84 CML cells showed a significant decrease in cellular proliferation when compared to control siRNA administered cells, according to a study on human chronic myelogenous leukaemia (CML) [156]. Here, AQP5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.